What are the risks to the newborn in cases of placenta previa?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Neonatal Risks in Placenta Previa

The primary risk to the newborn in placenta previa is prematurity and its associated complications, as approximately 67% of these infants are delivered preterm, with perinatal mortality currently at 4-8% primarily related to complications of prematurity. 1

Primary Neonatal Risks

Prematurity-Related Complications

  • Preterm delivery occurs in approximately 67% of placenta previa cases, making prematurity the dominant neonatal risk 1, 2
  • Planned cesarean delivery is recommended at 34 0/7 to 35 6/7 weeks of gestation for uncomplicated placenta previa, which inherently exposes the newborn to late preterm complications 3, 4
  • Earlier delivery may be required for persistent bleeding, preeclampsia, labor, rupture of membranes, or fetal compromise, further increasing prematurity risks 3
  • Antenatal corticosteroids should be administered when delivery is anticipated before 37 0/7 weeks to reduce neonatal respiratory complications 3, 4

Perinatal Mortality

  • Current perinatal mortality with placenta previa is 4-8%, primarily driven by complications of prematurity rather than direct hemorrhagic complications 1
  • This represents a dramatic improvement from historical outcomes due to advances in prenatal ultrasound, cesarean delivery, and transfusion medicine 5

Secondary Neonatal Risks

Complications from Maternal Hemorrhage

  • Antenatal bleeding, preterm labor, and preterm prelabor rupture of membranes are associated with both maternal and neonatal morbidity 6
  • Massive maternal hemorrhage requiring transfusion occurs frequently, which can compromise uteroplacental perfusion and fetal oxygenation 4
  • Approximately 50% of women with placenta accreta spectrum beyond 36 weeks require emergent delivery for hemorrhage, which increases risk of fetal compromise 3, 4

Risks from Associated Conditions

  • When placenta previa is diagnosed, assessment for placenta accreta spectrum and vasa previa is essential, as vasa previa carries risk of fetal exsanguination when membranes rupture 7
  • Women with placenta previa and prior cesarean deliveries have dramatically increased risk of placenta accreta spectrum (3% with no prior cesarean, up to 67% with five or more cesareans), which increases surgical complexity and duration of delivery 6

Optimizing Neonatal Outcomes

Delivery Planning to Minimize Neonatal Risk

  • Delivery must occur at a level III or IV maternal care facility with neonatology expertise immediately available 6, 3, 4
  • Preoperative coordination with neonatology is essential to prepare for potential resuscitation of a preterm infant 3, 4
  • The timing of delivery at 34 0/7 to 35 6/7 weeks balances neonatal complications against increased maternal bleeding risk after 36 weeks 3, 4

Critical Pitfall to Avoid

  • Delaying delivery beyond 36 0/7 weeks is not advised as the risk of emergent delivery for maternal hemorrhage increases substantially, which can result in delivery under suboptimal conditions with increased neonatal compromise 3, 4

References

Research

Placenta previa.

Clinics in perinatology, 1992

Research

Placenta previa: an analysis of three years experience.

American journal of perinatology, 1985

Guideline

Management and Treatment of Placenta Previa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Placenta Previa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Placenta Previa.

Clinical obstetrics and gynecology, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Placenta previa, placenta accreta, and vasa previa.

Obstetrics and gynecology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.